NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/02/2025
Voltar para busca
Dado oficial do USPTO
LINDUS HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
03/04/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 42, 45
Data de depósito
20/09/2023
Data de registro
25/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/02/2025
Última transação
03/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
LONDON, GB
Examinador
SIMCOX,KYLE DUNCAN
Unidade examinadora
N40
Localização atual
PETITIONS OFFICE
Descrição da marca
The mark consists of the stylized wording "LINDUS HEALTH", to the left of which are two overlapping circle designs, with one larger circle to the left of and partially overlapped by one smaller circle.
Titulares e representantes
Titulares
Lindus Health Ltd.
Representantes
RYAN S. HILBERT HOLLEY & MENKER PA
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Providing independent review of clinical trials for business purposes for the purpose of improvingconsulting onorganizingmanaging and optimizing clinical trials; Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting services in the field of clinical trials; Business advisory services in the field of clinical trials; Business information services in the field of clinical trials; none of the foregoing consisting of marketingmarketing consulting and market research services in the fields of biotechnology and the life sciences
Classe 42
Platform as a service (PAAS) featuring software for use in collectinganalyzingprocessingtrackingsynthesizingstoringorganizingexchangingsharingreportingtransmitting and distributing informationdataimagesaudiovideo and audiovisual materials in the fields of clinical research and clinical trials; Software as a service (SAAS) featuring software for use in collectinganalyzingprocessingtrackingsynthesizingstoringorganizingexchangingsharingreportingtransmitting and distributing informationdataimagesaudiovideo and audiovisual materials in the fields of clinical research and clinical trials; Technical support servicesinstallation and remote administration of softwaretroubleshooting of software problems and hosted software applicationsall for use in connection with clinical research and clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific researchconducting clinical trials for others; Medical and scientific researchdesigningorganizingconductingmonitoringmanaging clinical trials and studies for others; Providing information in the fields of clinical research and clinical trials via a website
Classe 45
Tracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
25/02/2025
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/02/2025
OP.T
OPPOSITION TERMINATED NO. 999999
03/02/2025
OP.D
OPPOSITION DISMISSED NO. 999999
03/02/2025
CHPB
POST PUBLICATION AMENDMENT - ENTERED
30/09/2024
APET
ASSIGNED TO PETITION STAFF
30/09/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
19/09/2024
OP.I
OPPOSITION INSTITUTED NO. 999999
19/09/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
17/09/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
20/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/05/2024
PUBO
PUBLISHED FOR OPPOSITION
21/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2024
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
18/03/2024
GPRA
PRIORITY ACTION E-MAILED
18/03/2024
CPRA
PRIORITY ACTION WRITTEN
18/03/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/03/2024
DOCK
ASSIGNED TO EXAMINER
27/02/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
18/12/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2023
NWAP
NEW APPLICATION ENTERED
23/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LINDUS HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.